PIAS3 expression in squamous cell lung cancer is low and predicts overall survival
R. Abbas(University Hospitals of Cleveland), Afshin Dowlati(University Hospitals of Cleveland)
Cited by 28
Related Papers
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|459
Management of Metabolic Effects Associated With Anticancer Agents Targeting the PI3K-Akt-mTOR Pathway
|Journal of Clinical Oncology|2012|231
Reciprocal expression of INSM1 and YAP1 defines subgroups in small cell lung cancer
|Oncotarget|2017|162
First-in-human study of REGN3767 (R3767), a human LAG-3 monoclonal antibody (mAb), ± cemiplimab in patients (pts) with advanced malignancies.
|Journal of Clinical Oncology|2019|38